GGI
MRNA icon

Godsey & Gibb Inc’s Moderna MRNA Stock Holding History

Godsey & Gibb Inc’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-176
Closed -$20.9K – 453
2024
Q2 		$20.9K Hold
176
– – ﹤0.01% 246
2024
Q1 		$18.8K Hold
176
– – ﹤0.01% 228
2023
Q4 		$17.5K Hold
176
– – ﹤0.01% 228
2023
Q3 		$18.2K Hold
176
– – ﹤0.01% 211
2023
Q2 		$21.4K Hold
176
– – ﹤0.01% 218
2023
Q1 		$27K Sell
176
-100
-36% -$16.5K ﹤0.01% 191
2022
Q4 		$49.6K Buy
+276
New +$45.1K 0.01% 119

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Godsey & Gibb Inc's MRNA Position: Q3 2024 in Review

Godsey & Gibb Inc sold out of Moderna (MRNA) in Q3 2024, closing a stake of 176 shares — an estimated $20.9K sold.

Godsey & Gibb Inc first reported a position in MRNA in Q4 2022 and held it in 7 quarters. The position peaked at $49.6K in Q4 2022. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Godsey & Gibb Inc reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Godsey & Gibb Inc sold 176 Moderna shares in Q3 2024, an estimated $20.9K.
  • Godsey & Gibb Inc first reported a position in Moderna in Q4 2022 and held it in 7 quarters.
  • Godsey & Gibb Inc's Moderna position peaked at $49.6K in Q4 2022.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Godsey & Gibb Inc's 13F filing for Q3 2024, filed 18 Oct 2024.